טוען...
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder
BACKGROUND: Lorcaserin, a high-affinity 5-HT(2C) receptor agonist approved for treating obesity, decreased self-administration of oxycodone and cue-induced reinstatement of drug-seeking behavior in preclinical studies. The current investigation is the first clinical trial to evaluate the ability of...
שמור ב:
| הוצא לאור ב: | Drug Alcohol Depend |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063580/ https://ncbi.nlm.nih.gov/pubmed/31980285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.107859 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|